NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.7% | +13.3% | -10.5% | +322.5% | -8.0% | -22.2% | -27.4% | -36.4% | -44.0% | -23.7% | -7.7% | |
| – | +21.5% | +21.8% | -23.3% | +339.9% | -1.1% | -19.9% | -30.1% | -31.4% | -39.4% | -21.0% | +1.9% | |
| – | +349.4% | +7.3% | -92.0% | +3,992.9% | -50.6% | +106.5% | -87.3% | +249.9% | -60.0% | +25.4% | -65.8% | |
| – | +29.9% | +25.9% | -23.9% | +350.9% | -0.8% | -19.8% | -30.9% | -31.2% | -39.9% | -15.9% | -3.7% | |
| – | +453.0% | -21.4% | -68.0% | +761.8% | -14.8% | +5.7% | -42.2% | -62.6% | -73.2% | -28.6% | +10.6% | |
| – | -12.4% | -2.1% | -3.4% | +6.1% | +11.3% | +20.7% | +3.3% | +21.5% | -16.1% | -100.0% | – | |
| – | +1.4% | -8.0% | -27.6% | +2.9% | +33.1% | -8.2% | +197.6% | -51.6% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +22.3% | -3.0% | -12.4% | +2.7% | +32.2% | -19.3% | -5.2% | -21.4% | -22.4% | -9.0% | -21.6% | |
| – | -4.4% | +17.9% | -22.2% | +46.0% | +331.6% | -67.3% | -26.4% | -19.9% | -24.8% | +19.8% | -12.8% | |
| – | +110.8% | -38.9% | +450.0% | +93.1% | +329.7% | -94.8% | +25.3% | +7.0% | +3.2% | +3.2% | +3.2% | |
| – | -12.6% | +19.2% | +69.8% | +22.4% | +228.6% | +15.1% | -56.0% | +33.2% | -24.1% | +17.4% | -6.8% | |
| – | +93.7% | +0.6% | +0.7% | +0.7% | – | – | – | – | – | – | – | |
| – | -82.3% | +1,270.7% | -0.3% | +1,855.6% | -18.2% | -23.3% | -36.9% | -46.0% | -64.3% | -53.6% | +47.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.4% | +5.4% | +11.7% | +15.5% | -2.8% | +2.1% | +2.6% | +2.1% | +1.5% | +8.2% | +23.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.